Distribution and antimicrobial activity of ciprofloxacin in human soft tissues.
about
Importance of relating efficacy measures to unbound drug concentrations for anti-infective agentsIncrease of microcirculatory blood flow enhances penetration of ciprofloxacin into soft tissue.Penetration of ciprofloxacin into the interstitial space of inflamed foot lesions in non-insulin-dependent diabetes mellitus patientsIssues in pharmacokinetics and pharmacodynamics of anti-infective agents: distribution in tissue.Tissue pharmacokinetics of levofloxacin in human soft tissue infections.Electroporation and transcutaneous sampling (ETS) of acyclovir.Transcutaneous sampling of ciprofloxacin and 8-methoxypsoralen by electroporation (ETS technique).Dermal drug levels of antibiotic (cephalexin) determined by electroporation and transcutaneous sampling (ETS) technique.[18F]Ciprofloxacin, a new positron emission tomography tracer for noninvasive assessment of the tissue distribution and pharmacokinetics of ciprofloxacin in humans.A whole-body physiologically based pharmacokinetic (WB-PBPK) model of ciprofloxacin: a step towards predicting bacterial killing at sites of infection.Population Pharmacokinetic Modeling as a Tool To Characterize the Decrease in Ciprofloxacin Free Interstitial Levels Caused by Pseudomonas aeruginosa Biofilm Lung Infection in Wistar Rats.Distribution and antimicrobial activity of fosfomycin in the interstitial fluid of human soft tissues.Target site concentrations of ciprofloxacin after single intravenous and oral dosesConcentrations of gemifloxacin at the target site in healthy volunteers after a single oral dose.AI-2/LuxS is involved in increased biofilm formation by Streptococcus intermedius in the presence of antibiotics.
P2860
Q26827380-755C03E5-8111-43C9-AF03-9AF0AF1DD081Q33224086-D98D7E40-E7FE-401D-86F9-55220C9504C7Q33977488-91C792DE-0FEC-4D5F-BD56-76029060A65AQ35754443-E8D511F1-A64C-4CA6-8B7E-958EFC6A7A89Q35826148-E0A94773-5622-44F4-909B-8A3320AF58F4Q36498743-0B4D1D5A-7060-45E6-814F-339C10BDBBECQ37183990-8596A45A-05D2-43A2-8CC4-45A0ABB46617Q37335289-3061CA7F-F310-464D-8516-E160262E99C3Q37568411-0734B367-8AAB-4983-A0B3-A0EBD20C4C5FQ37733479-8CBC964D-CD5F-44B4-8F97-52633FB7BC33Q38810304-9032E877-3E09-46DE-9BE6-4165D46392A5Q39475307-BB738B46-1A51-4D34-BF3A-BA741E90BF72Q39671107-269EF8D8-C334-4BEF-8437-B964D3C5800EQ40290562-8B4EDDED-DD6E-4FAD-AC13-18DFC1375A65Q42112385-B6895AEC-A3AE-404F-8054-26A6E183F332
P2860
Distribution and antimicrobial activity of ciprofloxacin in human soft tissues.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
1999年论文
@zh
1999年论文
@zh-cn
name
Distribution and antimicrobial activity of ciprofloxacin in human soft tissues.
@en
Distribution and antimicrobial activity of ciprofloxacin in human soft tissues.
@nl
type
label
Distribution and antimicrobial activity of ciprofloxacin in human soft tissues.
@en
Distribution and antimicrobial activity of ciprofloxacin in human soft tissues.
@nl
prefLabel
Distribution and antimicrobial activity of ciprofloxacin in human soft tissues.
@en
Distribution and antimicrobial activity of ciprofloxacin in human soft tissues.
@nl
P2093
P2860
P1476
Distribution and antimicrobial activity of ciprofloxacin in human soft tissues.
@en
P2093
A Georgopoulos
H G Eichler
S Delacher
U Hollenstein
P2860
P304
P407
P577
1999-05-01T00:00:00Z